Tamoxifen FDA Link Generic

One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

Also Known As:

ICI-46,474; ICI-46474; ICI-47699; Nolvadex; Novaldex; Soltamox; Tamoxifen Citrate; Tomaxithen; Zitazonium; Citrate, Tamoxifen; ICI 46,474; ICI 46474; ICI 47699; ICI46,474; ICI46474; ICI47699; Ethanamine, 2- (4- (1,2- diphenyl- 1- butenyl)phenoxy)- N,N- dimethyl- , (Z)-

Pharmalogical Action Categories:

Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Selective Estrogen Receptor Modulators

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        Stilbenes: 657
        Tamoxifen: 14288

Rordlamool Paytai Selected Research

Rordlamool Paytai Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure